Toggle light / dark theme

More than 107 million science papers have just been cataloged for the public’s use thanks to a new project called The General Index.

Typically, academic studies exist behind a paywall — locking up potentially important information not only from the public but, perhaps more importantly, from other scientists.

The General Index wants to set that information free. The index acts almost like a Google search for scientific papers, but with a twist. Only snippets of the papers are provided, so it is up to users to mine the data and make sense out of it all.

Published in the journal Quantum Science and Technology, Saleh’s research focused on a novel quantum computing technique that should — at least on paper — be able to reconstitute a small object across space “without any particles crossing.”

While it’s an exciting prospect, realizing his vision will require a lot more time and effort — not to mention next-generation quantum computers that haven’t been designed, let alone built yet. That is if it’s even possible at all.

Counterportation can be achieved, the study suggests, by the construction of a small “local wormhole” in a lab — and as the press release notes, plans are already underway to actually build the groundbreaking technology described in the paper.

Recent research reveals that a peptide called “Nickelback” may have played a huge role in kick-starting life on earth. The substance may also serve as a clue in the long-standing search for extraterrestrial intelligence.

Nickelback Peptide Molecule

A research team from Rutgers University and the City College of New York was able to pinpoint a simple peptide protein called nickelback. While it mirrors the name of a famous Canadian rock band, the name of the peptide refers to the backbone of the protein, which consists of two atoms of nitrogen linked to a nickel atom pair and an amino acid chain.

Driving Toward the Elimination of Cancer — Joel Greshock — VP, Oncology, Data Science & Digital Health, Janssen Pharmaceutical Companies of Johnson & Johnson.


Joel Greshock is VP, Oncology, Data Science & Digital Health, Janssen Research & Development (https://www.janssen.com/oncology/leadership-team). In this position, he is responsible for creating unique and actionable medical insights using large and increasingly available datasets. The focus of this research includes discovering novel therapeutic targets, identifying areas of unmet medical need, and enhancing clinical trial recruitment and execution.

Prior to joining Janssen R&D, Joel served as Vice President of Bioinformatics at Neon Therapeutics, Inc., where he built and managed the Data Sciences organization. At Neon, he was responsible for the design and deployment of personalized cancer therapies now under clinical evaluation.

We don’t learn by brute force repetition. AI shouldn’t either.


Despite impressive progress, today’s AI models are very inefficient learners, taking huge amounts of time and data to solve problems humans pick up almost instantaneously. A new approach could drastically speed things up by getting AI to read instruction manuals before attempting a challenge.

One of the most promising approaches to creating AI that can solve a diverse range of problems is reinforcement learning, which involves setting a goal and rewarding the AI for taking actions that work towards that goal. This is the approach behind most of the major breakthroughs in game-playing AI, such as DeepMind’s AlphaGo.

This post is also available in: he עברית (Hebrew)

According to a report done by Surfshark VPN, out of the approximately 5 billion of internet users, over 1.6 billion of them (31% of users) use a VPN. That’s close to a fifth of the worlds population.

A VPN, or a Virtual Private Network, is a mechanism for creating a secure connection between a computing device and a computer network, or between two networks, using an insecure communication medium such as the public Internet. A VPN can extend a private network (one that disallows or restricts public access), enabling users to send and receive data across public networks as if their devices were directly connected to the private network.

https://youtube.com/watch?v=uYjjRAcI7x4&feature=share

For copyright contact: stienlemane2379(at)gmail.com.

Welcome to Futureunity, where we explore the fascinating world of science, technology, and the universe! From the inner workings of the human body to the outer reaches of space, we delve into the latest and most interesting discoveries that are shaping our world. Whether you’re a science buff or just looking for some mind-blowing facts, we’ve got you covered. Join us as we uncover the mysteries of the world around us and discover new frontiers in the fields of science and technology. Get ready for a journey that’s both educational and entertaining!

Disclaimer Fair Use:
1. The videos have no negative impact on the original works.
2. The videos we make are used for educational purposes.
3. The videos are transformative in nature.
4. We use only the audio component and tiny pieces of video footage, only if it’s necessary.
Copyright Disclaimer under section 107 of the Copyright Act 1976, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, education, and research. Fair use is a use permitted by copyright statutes that might otherwise be infringing.

Disclaimer:

In patients with multi-vessel heart disease who have had a heart attack, immediate treatment with stents in all diseased arteries was found to be as safe and effective at one year of follow-up as staged treatment, according to findings from the first large, randomized trial to address this question that is being presented at the American College of Cardiology’s Annual Scientific Session Together With the World Congress of Cardiology. In staged treatment, the blocked artery that caused the heart attack is treated with a stent immediately and other partially blocked arteries are treated in a second procedure up to six weeks later. This study was simultaneously published online in The Lancet at the time of presentation.

About half of patients who have a have multi-vessel heart disease—this means that in addition to having one completely blocked that caused their heart attack, they have additional narrowed coronary arteries that are at risk of becoming blocked or unstable, leading to another heart attack. Clinicians refer to the blocked artery that causes a heart attack as the “culprit lesion” and to the other at-risk arteries as “non-culprit lesions.”

“The purpose of the international, randomized BIOVASC trial was to compare outcomes for immediate and staged complete for patients with multi-vessel heart disease who have suffered a heart attack. The goal was not to determine which approach was superior but rather to establish whether immediate complete vascularization was ‘not inferior’ to the staged approach, which needed to be answered first,” said Roberto Diletti, MD, Ph.D., an interventional cardiologist at Erasmus Medical Center in Rotterdam, Netherlands, and lead author of the study.